Evidence map›Paper›PMID 40013801›Full record

ArticleJournal of virology2025

SFTSV NSs interacts with AGO2 to regulate the RNAi pathway for viral replication.

Nasir Javaid, Tae-Won Jang, Yuting Fu, Younho Choi

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. SFTSV NSs protein is a tick antiviral RNAi response suppressor.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Multidimensional mechanisms of SFTSV-host interactions: viral protein functions, mFrontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nasir JavaidFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.ORCID 0000-0001-8947-4621
Tae-Won JangFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.
Yuting FuFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.
Younho ChoiFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.ORCID 0000-0003-4719-3279

Funding

Reassortment of Bunyavirus in ticks and animal modelsR01AI171201 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI Jae U Jung · 2022 to 2026
$2.9M
NIAID NIH HHS R01 AI171201
6 · The paper itself

Abstract

RNA interference (RNAi) is a posttranscriptional gene silencing mechanism acting as an antiviral defense in eukaryotes. During viral replication, intermediate double-stranded RNAs are processed into virus-derived small interfering RNAs (vsiRNAs) by the host enzyme, DICER. These vsiRNAs are incorporated into the RNA-induced silencing complex (RISC), where AGO2 cleaves viral genomic RNAs. However, viruses have evolved mechanisms to suppress this pathway. Here, we report that the nonstructural protein (NSs) of severe fever with thrombocytopenia syndrome virus (SFTSV) interacts with RISC to suppress the RNAi pathway. NSs forms a ternary complex by interacting with both DICER and AGO2 of the RNAi pathway. The interaction between NSs and DICER, facilitated by the two RNase III domains of DICER, is disrupted in the absence of AGO2 or the DICER-interacting domain (PIWI) of AGO2, indicating a direct interaction between NSs and AGO2. Functional assays using shRNA- and siRNA-mediated silencing of GFP signal, along with co-localization studies, demonstrated that NSs competes with siRNA to interact with AGO2, thereby abolishing RNAi activity. Mutational analysis identified an NSs-A26 mutant that no longer interacts with AGO2 and is unable to suppress RNAi activity, suggesting that NSs acts as a viral suppressor of RNAi (VSR) for SFTSV. Viral infection led to the generation of vsiRNA and showed higher replication in

Indexed as

Argonaute ProteinsPhlebovirusRNA InterferenceViral Nonstructural ProteinsVirus ReplicationAnimalsCell LineDEAD-box RNA HelicasesHEK293 CellsHost-Pathogen InteractionsHumansRibonuclease IIIRNA-Induced Silencing ComplexRNA, Small InterferingRNA, ViralAGO2 protein, humanArgonaute ProteinsDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease IIIRNA-Induced Silencing ComplexRNA, Small InterferingRNA, ViralViral Nonstructural Proteinsbunyavirusnonstructural proteinRNAiSFTSVviral replication

Identifiers

PMID40013801
PMCPMC11998505

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.